Amy M Lin Selected Research

Amy M Lin Research Topics

Disease

20	Prostatic Neoplasms (Prostate Cancer) 02/2019 - 05/2006
10	Neoplasms (Cancer) 11/2016 - 05/2006
4	Disease Progression 12/2017 - 10/2006
2	Stroke (Strokes) 10/2020 - 01/2019
1	Chronic Disease (Chronic Diseases) 10/2020
1	Neoplasm Metastasis (Metastasis) 02/2019
1	Obesity 01/2019
1	Anorexia 01/2018
1	Fatigue 01/2018
1	Nausea 01/2018
1	Circulating Neoplastic Cells 12/2017
1	Adenoma (Adenomas) 08/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2012
1	Hyperuricemia 09/2011
1	Pancreatitis 09/2011
1	Gout 09/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2011
1	Exanthema (Rash) 09/2011
1	Homocystinuria 12/2009
1	Methylmalonic acidemia 12/2009
1	Margins of Excision 05/2008
1	Leukemia 05/2006

Drug/Important Bio-Agent (IBA)

6	Prednisone (Sone)FDA LinkGeneric 12/2017 - 03/2007
6	Hormones (Hormone)IBA 01/2012 - 05/2006
5	AndrogensIBA 02/2019 - 05/2007
5	Prostate-Specific Antigen (Semenogelase)IBA 02/2019 - 10/2006
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2016 - 01/2009
4	Docetaxel (Taxotere)FDA Link 06/2015 - 03/2007
3	Abiraterone AcetateIBA 12/2017 - 12/2014
2	abirateroneIBA 01/2018 - 12/2017
2	IpilimumabIBA 09/2015 - 01/2009
2	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 08/2014 - 01/2012
2	Insulin-Like PeptidesIBA 07/2012 - 01/2012
2	Bevacizumab (Avastin)FDA Link 01/2011 - 05/2006
2	sipuleucel-T (APC8015)FDA Link 10/2007 - 09/2006
2	Imatinib Mesylate (Gleevec)FDA Link 06/2007 - 10/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2019
1	Testosterone (Sustanon)FDA Link 02/2019
1	CholesterolIBA 01/2019
1	enzalutamideIBA 01/2018
1	selinexorIBA 01/2018
1	Dehydroepiandrosterone (DHEA)IBA 12/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	dactolisibIBA 01/2017
1	cabazitaxel FDA Link 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	sargramostim (Leukine)FDA Link 09/2015
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	VaccinesIBA 09/2015
1	Ketoconazole (Nizoral)FDA LinkGeneric 12/2014
1	Steroid Synthesis InhibitorsIBA 12/2014
1	Prostaglandin D2IBA 08/2014
1	Messenger RNA (mRNA)IBA 08/2014
1	prostaglandin D2 receptorIBA 08/2014
1	EnzymesIBA 08/2014
1	Peptides (Polypeptides)IBA 07/2012
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2012
1	Insulin (Novolin)FDA Link 07/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2012
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2012
1	IsoenzymesIBA 01/2012
1	Masoprocol (Actinex)FDA Link 01/2012
1	ProstaglandinsIBA 01/2012
1	Prostaglandins DIBA 01/2012
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2012
1	Everolimus FDA Link 09/2011
1	Tyrosine Kinase InhibitorsIBA 09/2011
1	Sorafenib (BAY 43-9006)FDA Link 09/2011
1	TOR Serine-Threonine KinasesIBA 09/2011
1	Lipase (Acid Lipase)FDA Link 09/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2009
1	AntigensIBA 01/2009
1	taxaneIBA 05/2008
1	pertuzumabIBA 10/2007
1	N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA 10/2007
1	Taxoids (Taxanes)IBA 06/2007
1	Warfarin (Coumadin)FDA LinkGeneric 06/2007
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2007
1	Estramustine FDA Link 06/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2007
1	Finasteride (Propecia)FDA LinkGeneric 05/2007
1	prostatic acid phosphataseIBA 09/2006
1	Angiogenesis InhibitorsIBA 05/2006

Therapy/Procedure

9	Therapeutics 02/2019 - 09/2006
9	Castration 01/2018 - 01/2009
6	Drug Therapy (Chemotherapy) 01/2017 - 05/2006
3	Immunotherapy 06/2015 - 09/2006
1	Ambulatory Care (Outpatient Care) 10/2020
1	Prostatectomy (Retropubic Prostatectomy) 11/2016
1	Adjuvant Radiotherapy 05/2008